Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biofrontera (BFRI) EBIT Margin: 2021-2024

Historic EBIT Margin for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to -46.11%.

  • Biofrontera's EBIT Margin fell 3480.00% to -89.84% in Q3 2025 from the same period last year, while for Sep 2025 it was -47.40%, marking a year-over-year increase of 736.00%. This contributed to the annual value of -46.11% for FY2024, which is 2044.00% up from last year.
  • According to the latest figures from FY2024, Biofrontera's EBIT Margin is -46.11%, which was up 30.72% from -66.56% recorded in FY2023.
  • In the past 5 years, Biofrontera's EBIT Margin ranged from a high of -46.11% in FY2024 and a low of -104.57% during FY2021.
  • Over the past 3 years, Biofrontera's median EBIT Margin value was -64.80% (recorded in 2022), while the average stood at -59.16%.
  • As far as peak fluctuations go, Biofrontera's EBIT Margin soared by 3,977bps in 2022, and later tumbled by 176bps in 2023.
  • Yearly analysis of 4 years shows Biofrontera's EBIT Margin stood at -104.57% in 2021, then skyrocketed by 3,977bps to -64.80% in 2022, then crashed by 176bps to -66.56% in 2023, then spiked by 2,044bps to -46.11% in 2024.